Authors:
PRESTON SL
DRUSANO GL
BERMAN AL
FOWLER CL
CHOW AT
DORNSEIF B
REICHL V
NATARAJAN J
CORRADO M
Citation: Sl. Preston et al., PHARMACODYNAMICS OF LEVOFLOXACIN - A NEW PARADIGM FOR EARLY CLINICAL-TRIALS, JAMA, the journal of the American Medical Association, 279(2), 1998, pp. 125-129
Authors:
PRESTON SL
DRUSANO GL
BERMAN AL
FOWLER CL
CHOW AT
DORNSEIF B
REICHL V
NATARAJAN J
WONG FA
CORRADO M
Citation: Sl. Preston et al., LEVOFLOXACIN POPULATION PHARMACOKINETICS AND CREATION OF A DEMOGRAPHIC-MODEL FOR PREDICTION OF INDIVIDUAL-DRUG CLEARANCE IN PATIENTS WITH SERIOUS COMMUNITY-ACQUIRED INFECTION, Antimicrobial agents and chemotherapy, 42(5), 1998, pp. 1098-1104
Authors:
CHIEN SC
WONG FA
FOWLER CL
CALLERYDAMICO SV
WILLIAMS RR
NAYAK R
CHOW AT
Citation: Sc. Chien et al., DOUBLE-BLIND EVALUATION OF THE SAFETY AND PHARMACOKINETICS OF MULTIPLE ORAL ONCE-DAILY 750-MILLIGRAM AND 1-GRAM DOSES OF LEVOFLOXACIN IN HEALTHY-VOLUNTEERS, Antimicrobial agents and chemotherapy, 42(4), 1998, pp. 885-888
Authors:
CHIEN SC
CHOW AT
ROGGE MC
WILLIAMS RR
HENDRIX CW
Citation: Sc. Chien et al., PHARMACOKINETICS AND SAFETY OF ORAL LEVOFLOXACIN IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS RECEIVING CONCOMITANT ZIDOVUDINE, Antimicrobial agents and chemotherapy, 41(8), 1997, pp. 1765-1769
Authors:
CHIEN SC
CHOW AT
NATARAJAN J
WILLIAMS RR
WONG FA
ROGGE MC
NAYAK RK
Citation: Sc. Chien et al., ABSENCE OF AGE AND GENDER EFFECTS ON THE PHARMACOKINETICS OF A SINGLE500-MILLIGRAM ORAL DOSE OF LEVOFLOXACIN IN HEALTHY-SUBJECTS, Antimicrobial agents and chemotherapy, 41(7), 1997, pp. 1562-1565
Authors:
CHIEN SC
ROGGE MC
GISCLON LG
CURTIN C
WONG F
NATARAJAN J
WILLIAMS RR
FOWLER CL
CHEUNG WK
CHOW AT
Citation: Sc. Chien et al., PHARMACOKINETIC PROFILE OF LEVOFLOXACIN FOLLOWING ONCE-DAILY 500-MILLIGRAM ORAL OR INTRAVENOUS DOSES, Antimicrobial agents and chemotherapy, 41(10), 1997, pp. 2256-2260
Authors:
WALDMAN SA
VITOW C
OSBORNE B
GILLEN L
ARGENTIERI DC
WONG FA
SMITH IL
CHOW AT
MISITI J
BJORNSSON TD
Citation: Sa. Waldman et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF TEPOXALIN AFTER SINGLE ORAL DOSE ADMINISTRATION TO HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 36(5), 1996, pp. 462-468
Authors:
CHILD J
MORTIBOY D
ANDREWS JM
CHOW AT
WISE R
Citation: J. Child et al., OPEN-LABEL CROSSOVER STUDY TO DETERMINE PHARMACOKINETICS AND PENETRATION OF 2 DOSE REGIMENS OF LEVOFLOXACIN INTO INFLAMMATORY FLUID, Antimicrobial agents and chemotherapy, 39(12), 1995, pp. 2749-2751
Authors:
GOODWIN SD
GALLIS HA
CHOW AT
WONG FA
FLOR SC
BARTLETT JA
Citation: Sd. Goodwin et al., PHARMACOKINETICS AND SAFETY OF LEVOFLOXACIN IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Antimicrobial agents and chemotherapy, 38(4), 1994, pp. 799-804
Citation: Sc. Flor et al., BIOEQUIVALENCE OF ORAL AND INTRAVENOUS OFLOXACIN AFTER MULTIPLE-DOSE ADMINISTRATION TO HEALTHY MALE-VOLUNTEERS, Antimicrobial agents and chemotherapy, 37(7), 1993, pp. 1468-1472
Citation: At. Chow et al., HIGH-PRESSURE LIQUID-CHROMATOGRAPHIC ASSAY OF THEOPHYLLINE IN DOG FECES FOLLOWING ORAL-ADMINISTRATION OF SUSTAINED-RELEASE PRODUCTS, Journal of pharmaceutical sciences, 82(9), 1993, pp. 956-958